raw data-Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease
收藏官方服务：
资源简介：
research data of the work
应用场景：
创建时间：
2021-04-14
相关数据集
Table_2_Cortical Thickness Differences Are Associated With Chemical Synaptic Transmission Upregulated Genes in Degeneration of Mild Cognitive Impairment.xlsx
Mild cognitive impairment (MCI) is a transition between normal cognition (NC) and Alzheimer’s disease (AD). Differences in cortical thickness (ΔCT) have been reported in cases that degenerate from MCI
NIAID Data Ecosystem140
Table_2_The Key Factors Predicting Dementia in Individuals With Alzheimer’s Disease-Type Pathology.DOCX
Dementia affects millions of individuals worldwide, yet there are no effective treatments. Alzheimer’s disease, the most common form of dementia, is characterized by amyloid and tau pathology with amy
NIAID Data Ecosystem50
The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
A major difference in the revised diagnostic criteria for Alzheimer’s disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow the identification of preclinical AD due
NIAID Data Ecosystem30
Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature review
Alzheimer’s disease (AD) is the most common cause of dementia and is characterized by aggregation of amyloid and tau proteins in the brain. Results from genetic studies suggest that the pathophysiolog
NIAID Data Ecosystem50
Additional file 4 of Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer’s disease and implicate its dynamic role in disease progression
Additional file 4. Table S4: P values for the regression lines between the β values of the 10 CpG probes and the gene expression of PM20D1.
Figshare2024-02-14 更新40
